Your browser doesn't support javascript.
loading
Evaluating the clinical impact of the 2023 FIGO staging for endometrial cancer: Complexities and considerations.
Ouldamer, Lobna; Koskas, Martin; Carcopino, Xavier.
Affiliation
  • Ouldamer L; Department of Gynecology. CHRU de Tours, Hôpital Bretonneau, 2 boulevard Tonnellé, 37044 Tours, France; François Rabelais University, Tours, France; INSERM Unit 1069, Tours, France. Electronic address: l.ouldamer@chu-tours.fr.
  • Koskas M; Department of Gynecology and Obstetrics, APHP, Hôpital Bichat, Paris, France; Université Paris-Saclay, UVSQ, Unité de Recherche 7285, Risques Cliniques et Sécurité en Santé des Femmes et en Santé Périnatale (RISCQ), Montigny-le-Bretonneux, France.
  • Carcopino X; Department of Obstetrics and Gynaecology, Hôpital Nord, APHM, Aix-Marseille University (AMU), Univ Avignon, CNRS, IRD, IMBE UMR 7263, 13397 Marseille, France.
Eur J Obstet Gynecol Reprod Biol ; 291: 59-60, 2023 12.
Article in En | MEDLINE | ID: mdl-37832479
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms Limits: Female / Humans Language: En Journal: Eur J Obstet Gynecol Reprod Biol Year: 2023 Document type: Article Country of publication: